FOX04-DRI 10mg

$139.99

  • Compound: FOXO4-DRI
  • Sequence: Supplied D-amino-acid sequence
  • Molecular Formula: C₂₂₈H₃₈₈N₈₆O₆₄
  • Molecular Weight: 5358 g/mol
  • Supplied PubChem CID: 167312269
  • CAS Number: 2460055-10-9
  • Vial Size: 3mL
  • Intended Use: Controlled laboratory research only

50 in stock

SKU: LPFOX10 Categories: , Tags: ,
Description

FOX04-DRI / FOXO4-DRI – Advanced Peptide Research Material

FOX04-DRI, supplied as FOXO4-DRI, is a peptide research material provided in a 3mL vial. The supplied molecular formula is C₂₂₈H₃₈₈N₈₆O₆₄, with a molecular weight of 5358 g/mol and CAS number 2460055-10-9.

The supplied product information identifies PubChem CID 167312269. Researchers should use the molecular characteristics and sequence when documenting the material and comparing it with scientific resources.

FOX04-DRI / FOXO4-DRI Research Overview

The FOX04-DRI search variation and supplied FOXO4-DRI product name refer to the research material described by the following specifications:

Specification Product Information
Compound FOXO4-DRI
Molecular Formula C₂₂₈H₃₈₈N₈₆O₆₄
Molecular Weight 5358 g/mol
Supplied PubChem CID 167312269
CAS Number 2460055-10-9
Vial Size 3mL

These characteristics provide reference information for molecular identification and laboratory documentation.

FOXO4-DRI Peptide Sequence

The supplied sequence is:

H-D-Leu-D-Thr-D-Leu-D-Arg-D-Lys-D-Glu-D-Pro-D-Ala-D-Ser-D-Glu-D-Ile-D-Ala-D-Gln-D-Ser-D-Ile-D-Leu-D-Glu-D-Ala-D-Tyr-D-Ser-D-Gln-D-Asn-D-Gly-D-Trp-D-Ala-D-Asn-D-Arg-D-Arg-D-Ser-D-Gly-D-Gly-D-Lys-D-Arg-D-Pro-D-Pro-D-Pro-D-Arg-D-Arg-D-Arg-D-Gln-D-Arg-D-Arg-D-Lys-D-Lys-D-Arg-D-Gly-OH

The sequence is an important part of the supplied molecular documentation and should be considered alongside the formula, molecular weight, CAS number, and other identifiers.

FOX04 Peptide Molecular Specifications

The search phrase fox04 peptide is another variation researchers may encounter when looking for information concerning this material.

The supplied specifications are:

  • Molecular Formula: C₂₂₈H₃₈₈N₈₆O₆₄
  • Molecular Weight: 5358 g/mol
  • CAS Number: 2460055-10-9
  • Vial Size: 3mL

The product information also lists PubChem CID 167312269.

PubChem note: The hyperlink supplied alongside that identifier points to PubChem compound 9941957, while the written product information states CID 167312269. Because these references conflict, the linked record should not be treated as confirmation of the supplied CID without independent verification.

FOXO4-DRI Molecular Identification

The keyword variation foxo4-dri closely matches the supplied compound name and is useful when reviewing research databases and scientific literature.

Researchers should rely on molecular characteristics rather than spelling variations alone when establishing identity.

Relevant supplied characteristics include the full D-amino-acid sequence, molecular formula C₂₂₈H₃₈₈N₈₆O₆₄, molecular weight 5358 g/mol, and CAS number 2460055-10-9.

Using multiple identifiers can reduce ambiguity when comparing the product with scientific records.

FOXO4-DRI Peptide Research

The phrase foxo4-dri peptide represents another relevant search variation for this material.

For laboratory research, the exact experimental material should be verified before findings from a publication are compared with another study.

Researchers may consider:

  • Peptide sequence
  • Molecular formula
  • Molecular weight
  • CAS number
  • Molecular identifier
  • Research model
  • Experimental concentration
  • Controls
  • Analytical methodology
  • Experimental endpoints

This helps distinguish research involving the specified material from studies involving different sequences or experimental systems.

FOX04 DRI and Search Variations

The alternative phrase fox04 dri is commonly formatted without a hyphen.

Search variations can help locate scientific information, but they should not override the supplied compound identity.

For this product, the supplied name remains FOXO4-DRI. Variations such as FOX04-DRI and FOX04 DRI are incorporated for search relevance while retaining the original product specification.

Researchers should confirm molecular identity before assuming differently formatted names describe identical materials.

FOX04-DRI 3mL Vial Format

The supplied FOX04-DRI research material is provided in a 3mL vial.

The vial capacity provides useful information for product identification and laboratory inventory.

It does not independently establish an experimental concentration, preparation volume, or research protocol.

No material strength, preparation solvent, reconstitution procedure, or experimental concentration was supplied in the provided product information. Those details are therefore not being inferred.

Laboratory Research Considerations

Controlled research involving FOXO4-DRI should use clearly documented methodology and appropriate experimental controls.

Relevant considerations can include:

  • Verification of material identity
  • Sequence documentation
  • Experimental concentration
  • Research model selection
  • Sample preparation
  • Appropriate controls
  • Exposure conditions
  • Analytical methodology
  • Experimental endpoints
  • Reproducibility
  • Data interpretation

Conclusions should remain limited to the experimental conditions and research model actually investigated.

FOXO4-DRI Research Documentation

Research records for this material can include:

  • Product name
  • Full sequence
  • Molecular formula
  • Molecular weight
  • Supplied PubChem identifier
  • CAS number
  • Vial capacity
  • Experimental concentration
  • Research model
  • Controls
  • Analytical method
  • Experimental endpoints

Detailed documentation is especially important where database identifiers or linked records conflict.

In this case, researchers should independently verify the PubChem information before using it as definitive molecular identification.

Scientific Data Interpretation

Scientific publications should be evaluated according to the material and methodology actually investigated.

A publication involving a similarly named material should not automatically be considered directly applicable unless the relevant molecular identity is confirmed.

Researchers should also distinguish findings obtained from different research models, experimental concentrations, controls, exposure conditions, and analytical methods.

These factors can materially affect how experimental observations are interpreted.

Related OROS Research Materials

Researchers exploring additional laboratory materials can review VIP 10mg as a separately specified research product.

Another catalog option is 5-Amino-1MQ 50mg.

Researchers interested in a multi-component research formulation can also explore AEGIS – BPC-157 / TB-500 / KPV.

These materials have different specifications and should not be considered chemically or experimentally interchangeable with FOXO4-DRI.

Scientific Research Resources

Researchers can use PubChem to investigate available chemical records, molecular identifiers, and compound information.

Peer-reviewed biomedical and experimental literature can be searched through PubMed.

When reviewing scientific publications, researchers should confirm the exact material, sequence, experimental model, methodology, controls, and endpoints before relating findings to another experiment.

FOX04-DRI Research FAQ

What is FOX04-DRI?

FOX04-DRI is a search variation associated with the supplied compound name FOXO4-DRI. This product is specified as a peptide research material supplied in a 3mL vial.

Is FOX04-DRI the same spelling as FOXO4-DRI?

No. The supplied compound name uses FOXO4-DRI with the letter “O,” while FOX04-DRI uses a zero and appears in the supplied keyword research. This page preserves that distinction.

What is the molecular formula?

The supplied molecular formula is C₂₂₈H₃₈₈N₈₆O₆₄.

What is the molecular weight?

The supplied molecular weight is 5358 g/mol.

What is the CAS number?

The supplied CAS number is 2460055-10-9.

What is the PubChem CID?

The supplied product data states 167312269. However, the provided hyperlink points to PubChem compound 9941957, so the CID/link combination should be independently verified.

What size vial is supplied?

The material is supplied in a 3mL vial.

Is a research concentration specified?

No experimental concentration or material strength was supplied in the provided specifications, so none is being inferred.

Research Use Disclaimer

This FOXO4-DRI material is supplied exclusively for controlled laboratory investigation, analytical evaluation, and applicable in-vitro research. It is not intended for human or animal consumption, injection, therapeutic application, diagnosis, clinical use, self-administration, anti-aging treatment, bodybuilding, performance enhancement, or veterinary application. Experimental work should be performed by qualified personnel using appropriately validated laboratory procedures.

Additional information
Net Weight

10mg

Brand

OROS Research

Format

Lyophilized Vial

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “FOX04-DRI 10mg”

Your email address will not be published. Required fields are marked *